ImmunityBio recently reported positive clinical data from its ANKTIVA (nogapendekin alfa inbakicept) program in non-small ...
3h
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...
Ooops... Something went wrong while loading this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback